Convalescent serum therapy for COVID-19: A 19th century remedy for a 21st century disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Convalescent serum therapy for COVID-19: A 19th century remedy for a 21st century disease
Authors
Keywords
Blood plasma, COVID 19, Antibodies, Antibody therapy, Respiratory infections, SARS, Blood transfusion, Elimination half-life calculation
Journal
PLoS Pathogens
Volume 16, Issue 8, Pages e1008735
Publisher
Public Library of Science (PLoS)
Online
2020-08-13
DOI
10.1371/journal.ppat.1008735
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
- (2020) Chih-Cheng Lai et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- Is COVID-19 receiving ADE from other coronaviruses?
- (2020) Jason A. Tetro MICROBES AND INFECTION
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
- (2020) Chenguang Shen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The convalescent sera option for containing COVID-19
- (2020) Arturo Casadevall et al. JOURNAL OF CLINICAL INVESTIGATION
- Convalescent serum lines up as first-choice treatment for coronavirus
- (2020) Cormac Sheridan NATURE BIOTECHNOLOGY
- Effectiveness of convalescent plasma therapy in severe COVID-19 patients
- (2020) Kai Duan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
- (2020) Ruklanthi de Alwis et al. EBioMedicine
- Origin and evolution of pathogenic coronaviruses
- (2018) Jie Cui et al. NATURE REVIEWS MICROBIOLOGY
- Immune correlates of protection for dengue: State of the art and research agenda
- (2017) Leah C. Katzelnick et al. VACCINE
- Remembering Emil von Behring: from Tetanus Treatment to Antibody Cooperation with Phagocytes
- (2017) Stefan H. E. Kaufmann mBio
- Hyperimmune IV Immunoglobulin Treatment
- (2013) Ivan F.N. Hung et al. CHEST
- Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection
- (2011) I. F. Hung et al. CLINICAL INFECTIOUS DISEASES
- Therapeutic antibodies: successes, limitations and hopes for the future
- (2009) Patrick Chames et al. BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started